Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors - US Advisor
For Financial Professionals in the US

Global Life Sciences Fund Holdings

Full Portfolio Holdings

(As of 01/31/2026)

% OF INVESTMENTS
Eli Lilly & Co 9.26
Johnson & Johnson 6.36
AstraZeneca PLC 4.26
AbbVie Inc 3.38
UnitedHealth Group Inc 3.02
Novartis AG (ADR) 2.66
Argenx SE (ADR) 2.64
Roche Holding AG 2.43
Praxis Precision Medicines Inc 2.43
Abbott Laboratories 2.42
Thermo Fisher Scientific Inc 2.40
Boston Scientific Corp 2.27
Amgen Inc 2.21
Intuitive Surgical Inc 2.13
Bridgebio Pharma Inc 2.11
Vertex Pharmaceuticals Inc 2.09
REVOLUTION Medicines Inc 2.07
Sanofi SA 2.02
HCA Healthcare Inc 1.99
Stryker Corp 1.79
Danaher Corp 1.69
Ascendis Pharma A/S (ADR) 1.57
CVS Health Corp 1.47
Mirum Pharmaceuticals Inc 1.31
Teva Pharmaceutical Industries Ltd (ADR) 1.29
McKesson Corp 1.28
Gilead Sciences Inc 1.26
Globus Medical Inc 1.26
Elevance Health Inc 1.23
Medtronic PLC 1.22
PTC Therapeutics Inc 1.22
Madrigal Pharmaceuticals Inc 1.17
Cencora Inc 1.07
United Therapeutics Corp 1.00
Vaxcyte Inc 0.97
Structure Therapeutics Inc (ADR) 0.94
Dyne Therapeutics Inc 0.83
Travere Therapeutics Inc 0.82
UCB SA 0.73
Soleno Therapeutics Inc 0.71
Medline Inc 0.71
Edwards Lifesciences Corp 0.70
DexCom Inc 0.68
Penumbra Inc 0.66
Lantheus Holdings Inc 0.64
Becton Dickinson & Co 0.63
Glaukos Corp 0.54
Avidity Biosciences Inc 0.51
Cooper Cos Inc 0.48
Apogee Therapeutics Inc 0.46
Ideaya Biosciences Inc 0.45
Biohaven Ltd 0.45
Ardelyx Inc 0.44
STERIS PLC 0.40
Daiichi Sankyo Co Ltd 0.37
Heartflow Inc 0.37
Crinetics Pharmaceuticals Inc 0.37
Sotera Health Co 0.35
Neurocrine Biosciences Inc 0.35
Cogent Biosciences Inc 0.33
Tarsus Pharmaceuticals Inc 0.33
Edgewise Therapeutics Inc 0.33
Regeneron Pharmaceuticals Inc 0.33
Rhythm Pharmaceuticals Inc 0.33
Olema Pharmaceuticals Inc 0.32
Zoetis Inc 0.31
Alnylam Pharmaceuticals Inc 0.29
Scholar Rock Holding Corp 0.28
Illumina Inc 0.27
Centene Corp 0.27
Nuvalent Inc 0.27
Insulet Corp 0.26
Arcellx Inc 0.26
Protagonist Therapeutics Inc 0.24
Xenon Pharmaceuticals Inc 0.24
Mirum Pharmaceuticals Inc 0.24
KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD 0.23
Terns Pharmaceuticals Inc 0.22
Teleflex Inc 0.20
Avadel Pharmaceuticals PLC 0.19
Humana Inc 0.19
Janux Therapeutics Inc 0.18
Immunome Inc 0.17
4D Molecular Therapeutics Inc 0.14
Curevo Inc 0.10
Lexeo Therapeutics Inc 0.09
KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD 0.07
Loadsmart Inc 0.07
Magnolia Medical Technologies Inc 0.06
Element Biosciences Inc 0.05
Green Cross Holdings Corp 0.04
Sonoma Biotherapeutics Inc 0.04
PFIZER INC 0.04
Twinstrand Biosciences Inc 0.03
Sonoma Biotherapeutics Inc 0.02
Freenome Holdings Inc 0.02
Freenome Holdings Inc 0.02
Asher Biotherapeutics Inc 0.02
Attralus Inc 0.01
Hemoshear Therapeutics LLC 0.01
Heartflow Inc 0.01
Asher Biotherapeutics Inc 0.01
Novo Nordisk A/S 0.01
Cash & Equivalents 0.32
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.